World Class Drug Delivery Company
World Class Drug Delivery Company
World Class Drug Delivery Company
At BDD we have over 25 years experience developing, manufacturing and clinically testing pharmaceutical products. We offer a single point solution to get phase I clinical data faster by eliminating unnecessary steps that cost our clients time and money.
We call this Lean Clinical Development™
Lean Clinical Development disrupts and streamlines the traditional early drug development approach, accelerating timelines and reducing waste. Bringing together phase-appropriate development with “just in time” manufacturing and clinical agility, we deliver the fastest path to phase I data providing you with a competitive edge. As a combined site, CRO and GMP manufacturing facility, BDD offers a responsiveness and adaptability that larger CROs can’t match.
BDD have 25 years experience in drug delivery, developing advanced formulations to optimise therapeutic outcomes.
Our formulation capabilities span from simple capsule/tablet dosage forms for rapid clinical evaluation to complex modified release profiles using techniques like hot melt extrusion and our proprietary OralogiK technology.
BDD offer flexible GMP Manufacturing for early stage clinical trials. We provide cost effective, rapid GMP manufacturing of small batches of clinical trial supplies and matching placebo.
For clinical studies performed through our Lean Clinical Development pathway, we offer our clients just in time manufacturing, eliminating the need for lengthy stability programmes and accelerating time to first dose.
We have been conducting Phase I clinical studies for more than 20 years. With industry leading recruitment rates and integrated CRO and site service, BDD’s processes are designed to streamline the clinical pathway, reducing costs for our partners.
Our unique mix of medical and scientific staff means that we approach studies differently. Bringing together our in depth knowledge of formulation development and biopharmaceutics ensures a sound scientific basis for every study.
BDD has over 25 years’ success conducting early-phase confirmatory clinical trials.
BDD was founded in 1999 by scientists and has always placed great science at the absolute forefront of everything we do.
BDD has a superb, proven track record, working from formulation through to clinic, across hundreds of satisfied clients.
BDD’s Lean Clinical Development approach significantly reduces traditional development pathways.
BDD has, for decades, built a robust and effective volunteer and patient database, enabling an industry-leading 80.2% screening-to-enrolment rate. Your study starts on time with BDD.
“With industry leading scientific expertise in clinical imaging and drug product design, BDD was an ideal partner for early stage clinical evaluation of complex drug products and implementation of new imaging approaches.” – Matt Burke – Vice President, Technical Operations & Product Development.
Formerly Senior Director, Head of Drug Delivery and CMC Leader at GSK
“We are happy to collaborate with BDD Pharma – their technology as well as integrated setup for early exploratory clinical testing is a great match for us and allow us to advance our Parkinson´s disease program towards patients.” – Anders Brandt Elvang – Chief Business Officer
“BDD was able to think out of the box in approaching some unusual formulation challenges in our development program. We were able to work interactively with BDD to get our new drug formulation program off the ground.” – Thomas Jozefiak – Chief Scientific Officer
“Cingulate appreciates BDD’s collaborative approach which consistently takes into consideration our priorities. This has allowed us to progress our clinical program for our ADHD clinical candidate. We certainly can recommend BDD for anyone seeking a reliable partner.” – Laurie Myers – Chief Operating Officer
“We cannot thank this team enough for all the hard work that led us to this point! The flexibility, the promptness, the communication. One of the best sites we’ve worked with, a truly cohesive team.” – Kiana Robinson – Project Manager
World Class Drug Delivery Company
Glasgow Royal Infirmary
84 Castle St
Glasgow
G4 0SF, UK
+44 (0)141 552 8791
Bio-City Scotland
Bo’ness Road
Chapelhall, Newhouse
ML1 5UH, UK
+44 (0)141 404 9540
Contera Pharma and BDD Pharma announce dosing of first subject in a Phase 1 trial of CP-012, a novel formulation to treat nocturnal symptoms and morning akinesia in Parkinson´s disease